CiRC Biosciences is a biotech company developing potential cell therapy treatments for vision loss conditions.
CiRC Biosciences has raised $7.0M in total funding. The most recent round was Debt Financing. The last funding was announced in May 2024.
CiRC Biosciences is headquartered in Chicago, United States.
CiRC Biosciences is a biotech company developing potential cell therapy treatments for vision loss conditions.
CiRC Biosciences is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CiRC Biosciences — Funding & Investors." VCBacked, May 1, 2024, https://www.vcbacked.co/company/circ-biosciences. Accessed August 14, 2026.
VCBacked. (2024). CiRC Biosciences — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/circ-biosciences
{{cite web |title=CiRC Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/circ-biosciences |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated